75mg Braftovi Encorafenib Pharmaceutical Capsules

₹ 5,000 /Box
by: Narula Associates
★★★★★3.6 (52)
New Delhi
86% response rate
  • 75mg Braftovi Encorafenib Pharmaceutical Capsules - Image 1 by Narula Associates
  • 75mg Braftovi Encorafenib Pharmaceutical Capsules - Image 2 by Narula Associates
  • 75mg Braftovi Encorafenib Pharmaceutical Capsules - Image 3 by Narula Associates
Prescription/Non prescription
Prescription
Form
Capsules
Brand
Braftovi
Manufacturer
Pierre Fabre
Composition
Encorafenib
Strength
75mg
Treatment
Cancer Growth Blockers

75mg Braftovi Encorafenib Pharmaceutical Capsules are oral kinase inhibitor targeting mutant BRAF (V600E/K), supplied as hard‑gelatin capsules (stylized "A" on beige cap, "LGX 75 mg" on white body), approved for use in combination therapy for melanoma, colorectal cancer (with cetuximab ± mFOLFOX6), and non-small cell lung cancer—each requiring a confirmed BRAF V600 mutation

New Delhi
GST
2 yrs
★★★★★3.6 (52)

Looking to import from India?

View export-ready suppliers

Visit IndiaMART Export

Seller Ratings & Reviews

Seller's final rating is a weighted average of star ratings, review recency, content quality, and rater quality score.
3.6★★★★★★★★★★

52 reviews

526
44
33
21
118
User Satisfaction
81%

Response

57%

Quality

40%

Delivery

Top Local sellers near you forAnti Cancer Medicines

Explore Related Categories

About Narula Associates

Contact Number
+91-7949086528
Total Number of Employees
11 To 25 People
GST Registration Date
2025
GST Legal status
Proprietorship
GST Nature of business
Manufacturer
GST Turnover
Rs. 5 - 10 Crore
GST Additional NOB
Wholesale Business
Verified GST Number
07**********1ZD
IndiaMART Member Since
Mar 2024
Year of Establishment
1996
Exports to
Bangladesh, Nepal, United States Of America, Turkey, United Kingdom
Call Response Rate
86%

Additional Information

Availability
In Stock
Price
Excluding all taxes
Ships from
New Delhi